Alia Zehani

Alia Zehani

Auto-generated profile, based on publicly available information

Alia Zehani

Faculty of Medicine of Tunis, Pathology Department, University Tunis El-Manar of Tunis, Tunis, Tunisia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2025 in Archives of Craniofacial Surgery
Verified
Journal Article
Open access
PDF file
KAKhansa Abderrahmen
Khansa Abderrahmen
KGKhalil Ghedira
Khalil Ghedira
AZAlia Zehani
Alia Zehani
SKSkander Kedous
Skander Kedous
SBSofiene Bouali
Sofiene Bouali
Giant cell tumor (GCT) of bone is a benign tumor originating from undifferentiated mesenchymal cells of the bone marrow. It most commonly arises in the epiphyseal regions of long bones. The skull represents an extremely rare location for GCT. Certain radiologic features involving the temporal or sphenoid bone strongly suggest this diagnosis. Skull GCT is a locally aggressive condition, posing surgical challenges and exposing the patient to a considerable risk of recurrence. In this article, we describe the diagnosis and surgical management of two patients with GCT of the temporal bone. The first patient is a 24-year-old man who presented with progressive left temporal swelling and hearing loss. Computed tomography revealed a 5.6× 4.6× 4.2 cm osteolytic lesion of the left temporal bone. The patient underwent neartotal resection and exhibited no recurrence after 10 years of follow-up. The second patient was a 55-year-old man presenting with gradual hearing loss in the right ear and trismus. Computed tomography showed a 4.7× 4.2× 3 cm temporo-sphenoidal erosive lesion. Complete surgical resection was performed with a favorable outcome and no recurrence.

17 November 2025 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
MLMarwa Lakhal
Marwa Lakhal
SRSarra Ben Rejeb
Sarra Ben Rejeb
AZAlia Zehani
Alia Zehani
SHSlim Haouet
Slim Haouet
MKMaher Kharrat
Maher Kharrat
KBKhadija Bellil
Khadija Bellil
The microsatellite stable with epithelial to mesenchymal transition (MSS/EMT) subtype includes some of the most aggressive gastric tumors with the worst prognosis. The purpose of this study is to characterize the MSS/EMT subtype by investigating potential associations with clinicopathologic features and specific elements of the tumor microenvironment: tumor-infiltrating lymphocytes and tumor budding. From a retrospectively collected bi-centric cohort, we first selected microsatellite stable samples and then assessed the immunohistochemical expression of E-cadherin, β-catenin, and zinc finger E-box binding homeobox 1 to identify the epithelial to mesenchymal transition. Our findings revealed that the MSS/EMT subtype represented 43% of our series, which was a high prevalence compared to previous studies. This subtype included patients who were significantly younger than non-MSS/EMT patients ( p =  .017). It was associated with diffuse and mixed-type histology ( p =  .047) and with nonconventional carcinomas ( p =  .023). The MSS/EMT did not correlate with the advanced stage. Regarding the tumor microenvironment elements, the MSS/EMT subtype was associated with low density of tumor-infiltrating lymphocytes ( p < 10 −3 ), while no association was found with tumor budding score. In conclusion, the highly prevalent and distinct MSS/EMT gastric cancer subtype features low tumor-infiltrating lymphocyte density, suggesting an immunosuppressive tumor microenvironment and therapy resistance.